“National Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb leaves the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.”
“The administration is currently searching for a permanent replacement, Azar told the House Energy & Commerce Health Subcommittee Hearing. Gottlieb announced his resignation last week. He supported Sharpless’ appointment to the role, according to a person familiar with his thinking…”
“Sharpless took over as director of the National Cancer Institute on Oct. 17, 2017. He previously led the University of North Carolina’s Lineberger Comprehensive Cancer Center…” Read the full article here.
Source: National Cancer Institute Director Ned Sharpless named acting FDA commissioner – By Angelica LaVito, March 12, 2019. CNBC.
